Drug recall · April 27, 2022
Pink Pussycat SENSUAL ENHANCEMENT capsule recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Pink Pussycat SENSUAL ENHANCEMENT capsule, 3000mg, 1-count blister card, Manufactured for: Pink Pussycat Products - Chatsworth, CA 91311, UPC 8 91875 00462 6.
- Lots / codes
Lot: 2009066, Exp: 09/2023
- Quantity
- 120 blister cards
- Company
- Pink Toyz, Chatsworth, CA
- Distribution
- Nationwide in the USA via walmart.com online marketplace
- Initiated
- March 29, 2022 · Voluntary: Firm initiated
- Classified
- April 25, 2022
- Reported
- April 27, 2022
- Ended
- July 31, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.